skip to Main Content

Dr. Richards on Using PARP Inhibitors in Metastatic Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Donald A. Richards, MD, PhD, medical oncologist, Texas Oncology, discusses the potential benefits of PARP inhibitors in patients with metastatic pancreatic cancer who harbor somatic BRCA mutations.

Watch here . . . 

Back To Top